ReNeuron logo
ReNeuron logo

Presentations: Induced pluripotent stem cell (iPSC) Platform

Preliminary Results Presentation for the year ended 31 March 2020

To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.

A recording of the webcast can be accessed via the following link:

https://webcasting.buchanan.uk.com/broadcast/5f154afa4c167c1215797e02

Section: News

  • News

Filter by:

  • Corporate
  • Product
    • Induced pluripotent stem cell (iPSC) Platform
    • CTX cells for Stroke Disability
    • CTX cells for Critical Limb Ischaemia
    • hRPCs for Retinitis Pigmentosa
    • CTX-derived Exosomes
  • Trial
    • Phase III clinical trial in stroke disability (PISCES-III)
    • Phase I clinical trial in stroke disability (PISCES)
    • Phase II clinical trial in stroke disability (PISCES-II)
    • Observational study in stroke
    • Phase I trial in critical limb ischaemia
    • Phase I/II clinical trial in retinitis pigmentosa

© ReNeuron Group plc 2025 All rights reserved

Website design by Carr Kamasa Design

  • Privacy Notice
  • Disclaimer